Drug-AZD8931
D0102C00019
Phase 1 small_molecule terminated
Quick answer
Drug-AZD8931 for Breast Neoplasm is a Phase 1 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Breast Neoplasm
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated